Regulation of Na+-K+-ATPase leads to disturbances of isoproterenol-induced cardiac dysfunction via interference of Ca2+-dependent cardiac metabolism
Clinical Science · 2024
DOI: 10.1042/cs20231039 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Science, 2024. Verfasst von Xiaofei Yan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Xi'an Jiaotong University, Xi'an 710061, China. Hauptthemen laut MEDLINE: Myocytes, Cardiac, Heart Failure. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 2.0). Gefördert von: Key Research and Development (R&D) Project of Shaanxi, The Science and Technology Project of Shaanxi, National Natural Science Foundation of China (NSFC).
Abstract (Originalsprache)
Reductions in Na+-K+-ATPase (NKA) activity and expression are often observed in the progress of various reason-induced heart failure (HF). However, NKA α1 mutation or knockdown cannot cause spontaneous heart disease. Whether the abnormal NKA α1 directly contributes to HF pathogenesis remains unknown. Here, we challenge NKA α1+/- mice with isoproterenol to evaluate the role of NKA α1 haploinsufficiency in isoproterenol (ISO)-induced cardiac dysfunction. Genetic knockdown of NKA α1 accelerated ISO-induced cardiac cell hypertrophy, heart fibrosis, and dysfunction. Further studies revealed decreased Krebs cycle, fatty acid oxidation, and mitochondrial OXPHOS in the hearts of NKA α1+/- mice challenged with ISO. In ISO-treated conditions, inhibition of NKA elevated cytosolic Na+, further reduced mitochondrial Ca2+ via mNCE, and then finally down-regulated cardiac cell energy metabolism. In addition, a supplement of DRm217 alleviated ISO-induced heart dysfunction, mitigated cardiac remodeling, and improved cytosolic Na+ and Ca2+ elevation and mitochondrial Ca2+ depression in the NKA α1+/− mouse model. The findings suggest that targeting NKA and mitochondria Ca2+ could be a promising strategy in the treatment of heart disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Xi'an Jiaotong University, Xi'an 710061, China.
- Hospital of Nephrology, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, China.
- Department of Microbiology and Immunology, School of Basic Medical Sciences, Xi'an Jiaotong University, Xi'an 710061, China.
- Department of Clinical laboratory in Xi'an Fourth Hospital, Xi'an 710004, China.
ORCID-Profile: Xiaofei Yan
Förderung
- Key Research and Development (R&D) Project of Shaanxi
- The Science and Technology Project of Shaanxi
- National Natural Science Foundation of China (NSFC)
Zitieren
APA
Yan, X., Li, M., Lan, P., Xun, M., Zhang, Y., Shi, J., Wang, R., & Zheng, J. (2024). Regulation of Na+-K+-ATPase leads to disturbances of isoproterenol-induced cardiac dysfunction via interference of Ca2+-dependent cardiac metabolism. Clinical Science. https://doi.org/10.1042/cs20231039
Vancouver
Yan X, Li M, Lan P, Xun M, Zhang Y, Shi J, et al. Regulation of Na+-K+-ATPase leads to disturbances of isoproterenol-induced cardiac dysfunction via interference of Ca2+-dependent cardiac metabolism. Clinical Science. 2024. doi:10.1042/cs20231039
BibTeX
@article{Yan2024,
author = {Yan, Xiaofei and Li, Meihe and Lan, Ping and Xun, Meng and Zhang, Ying and Shi, Jinghui and Wang, Ruijia and Zheng, Jin},
title = {Regulation of Na+-K+-ATPase leads to disturbances of isoproterenol-induced cardiac dysfunction via interference of Ca2+-dependent cardiac metabolism},
journal = {Clinical Science},
year = {2024},
doi = {10.1042/cs20231039}
}
EUVIMED